Clinical Trial Update: Pharmacokinetic Evaluation of Testosterone Gel (1%) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic evaluation of testosterone gel 1% in individuals with primary or secondary hypogonadism and constitutional delay in growth and puberty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constitutional Delay of Growth and Puberty
• Hypogonadism

Drugs mentioned

• TESTOSTERONE GEL, 1% (TESTOSTERONE GEL, 1%)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP) | Phase 1 | Status: COMPLETED